[HTML][HTML] An approach for the extract generation and toxicological assessment of tobacco-free 'modern'oral nicotine pouches

E Bishop, N East, S Bozhilova, S Santopietro… - Food and chemical …, 2020 - Elsevier
E Bishop, N East, S Bozhilova, S Santopietro, D Smart, M Taylor, S Meredith, A Baxter…
Food and chemical toxicology, 2020Elsevier
Tobacco-free 'modern'oral nicotine pouches (MOPs), are similar in appearance and use to
Swedish-style snus, but without tobacco. There are few identified methods to create test
samples for toxicologically assessment of MOPs in vitro. In this study we present a simple
method for the extraction of pouch material in cell culture media, providing consistent
nicotine concentration and easy in vitro assessment. A series of contemporary in vitro
screening assays (viability, cell health markers, oxidative stress and genotoxicity) using …
Abstract
Tobacco-free ‘modern’ oral nicotine pouches (MOPs), are similar in appearance and use to Swedish-style snus, but without tobacco. There are few identified methods to create test samples for toxicologically assessment of MOPs in vitro.
In this study we present a simple method for the extraction of pouch material in cell culture media, providing consistent nicotine concentration and easy in vitro assessment. A series of contemporary in vitro screening assays (viability, cell health markers, oxidative stress and genotoxicity) using human oral fibroblasts (HGF) and human lung epithelial cells (H292) were employed. Extracts were generated from LYFT and compared to snus (CRP1.1) and cigarette (1R6F) reference products.
MOP and CRP1.1 extracts were generated by incubating one pouch in 20 ml of cell culture media, while 1R6F AqE was prepared by smoking 1 cigarette into 20 ml of cell culture media. 1R6F demonstrated toxicological responses in most assays; CRP1.1 had minimal to moderate effects while MOP demonstrated little or no response in all assays.
This study demonstrated the generation of MOPs extracts and their toxicological evaluation using in vitro screening approaches. Future product usage, pharmacokinetics and clinical studies will further substantiate the reduced risk potential of MOPs.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果